Biotech entity
Every one of those 2 sits in a single category, acquisition. Anne Wojcicki is most often covered alongside 23andMe, which appears in 2 of these 2 stories. Each story carries 2 original sources on average, compared with 6.5 for the broader beat in this window.
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, acquisition. Anne Wojcicki is most often covered alongside 23andMe, which appears in 2 of these 2 stories. Each story carries 2 original sources on average, compared with 6.5 for the broader beat in this window. That works out to roughly 0.8 stories per week across an 18-day span. Their average consequence score of 7 runs above the beat's 6.9 for that window. Anne Wojcicki appears in 2 tracked Biotech stories published from July 8, 2026 through July 25, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 83 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Anne Wojcicki. Shared-story counts are live from our verified record — not editorial picks.
23andMe's $46.75 million settlement for the 6.9 million customer data leak highlights the fragility of consumer genetic testing demand. Already in bankruptcy from declining interest, the breach reinforces trust erosion in direct-to-consumer genomics, prompting shifts in industry data stewardship standards.
For the biotech world, the 23andMe saga is a stark lesson: acquiring assets out of bankruptcy does not shield from inherited data-breach liabilities. Anne Wojcicki’s $305 million purchase now carries a $46.75 million settlement that could chill future investments in consumer genomics.
Source: Kali Hays (gb)
Anne Wojcicki is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
